Profit and Loss Results Results Snapshot
Figures in Cr
Consolidated - Profit And Loss Results
Mar'22
Mar'21
Mar'20
No of Months
12
12
12
Operating Income
50.00
40.00
39.00
Less :Inter divisional transfers
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
Net Sales
50.00
40.00
39.00
Expenditure (Ex Depriciation)
Stock Adjustments
-11.00
-2.00
1.00
Raw Materials Consumed
2.00
2.00
2.00
Power & Fuel Cost
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
Operating Expenses
45.00
27.00
27.00
General and Administration Expenses
-1.00
-1.00
-1.00
Selling and Distribution Expenses
1.00
2.00
0.00
Cost of Software developments
0.00
0.00
0.00
Miscellaneous Expenses
1.00
1.00
0.00
Expenses Capitalised
0.00
0.00
0.00
Total Expenditure
43.00
34.00
35.00
Operating Profit (PBDIT) excl Other Income
6.00
5.00
3.00
Other Income
0.00
0.00
0.00
Operating Profit (PBDIT)
6.00
5.00
3.00
Interest
1.00
1.00
0.00
Profit before Depriciation and Tax
5.00
4.00
3.00
Depreciation
0.00
0.00
0.00
Profit Before Taxation & Exceptional Items
5.00
3.00
2.00
Exceptional Income / Expenses
0.00
0.00
0.00
Profit Before Tax
5.00
3.00
2.00
Provision for Tax
0.00
0.00
0.00
Profit After Tax
5.00
4.00
2.00
Extraordinary Items
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
Profit Balance B/F
11.00
6.00
3.00
Profit Available for appropriations
16.00
11.00
6.00
Appropriations
16.00
11.00
6.00
Equity Dividend (%)
0.00%
0.00%
0.00%
Earnings Per Share
8.27
8.07
4.18
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 42.56% vs 17.96% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is 75.42% vs 14.92% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is -1.92% vs 26.50% in Mar 2024
Profit After Tax
YoY Growth in year ended Mar 2025 is 97.41% vs 13.81% in Mar 2024
Compare Profit and Loss Results of Indo US Bio-Tech
Figures in Cr
consolidated - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
50.00
364.00
-314.00
-86.26%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
50.00
364.00
-314.00
-86.26%
Expenditure (Ex Depriciation)
Stock Adjustments
-11.00
-102.00
91.00
89.22%
Raw Materials Consumed
2.00
12.00
-10.00
-83.33%
Power & Fuel Cost
0.00
1.00
-1.00
-100.00%
Employee Cost
0.00
32.00
-32.00
-100.00%
Operating Expenses
45.00
214.00
-169.00
-78.97%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
1.00
119.00
-118.00
-99.16%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
1.00
4.00
-3.00
-75.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
43.00
314.00
-271.00
-86.31%
Operating Profit (PBDIT) excl Other Income
6.00
49.00
-43.00
-87.76%
Other Income
0.00
4.00
-4.00
-100.00%
Operating Profit (PBDIT)
6.00
54.00
-48.00
-88.89%
Interest
1.00
10.00
-9.00
-90.00%
Profit before Depriciation and Tax
5.00
43.00
-38.00
-88.37%
Depreciation
0.00
3.00
-3.00
-100.00%
Profit Before Taxation & Exceptional Items
5.00
40.00
-35.00
-87.50%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
5.00
40.00
-35.00
-87.50%
Provision for Tax
0.00
1.00
-1.00
-100.00%
Profit After Tax
5.00
38.00
-33.00
-86.84%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
11.00
441.00
-430.00
-97.51%
Profit Available for appropriations
16.00
480.00
-464.00
-96.67%
Appropriations
16.00
480.00
-464.00
-96.67%
Equity Dividend (%)
0%
20%
-20.00
Earnings Per Share
8.27
20.14
-11.87
-58.94%
Profit And Loss - Net Sales
Net Sales 103.84 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 42.56% vs 17.96% in Mar 2024
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 18.94 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 75.42% vs 14.92% in Mar 2024
Profit And Loss - Interest
Interest 1.49 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -1.92% vs 26.50% in Mar 2024
Profit And Loss - Profit After Tax
Profit After Tax 16.27 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 97.41% vs 13.81% in Mar 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
